BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19476873)

  • 1. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
    Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
    J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures.
    Velstra B; van der Burgt YE; Mertens BJ; Mesker WE; Deelder AM; Tollenaar RA
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):1983-92. PubMed ID: 22763645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.
    Belluco C; Petricoin EF; Mammano E; Facchiano F; Ross-Rucker S; Nitti D; Di Maggio C; Liu C; Lise M; Liotta LA; Whiteley G
    Ann Surg Oncol; 2007 Sep; 14(9):2470-6. PubMed ID: 17594124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
    Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
    PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
    Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
    Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.
    Gast MC; Zapatka M; van Tinteren H; Bontenbal M; Span PN; Tjan-Heijnen VC; Knol JC; Jimenez CR; Schellens JH; Beijnen JH
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1773-83. PubMed ID: 21913038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the raw serum peptidomic pattern in glioma patients.
    Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
    Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
    Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
    Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Zhu XD; Su F; Liang ZG; Li L; Qu S; Liang X; Wang Q; Liang SX; Chen L
    Int J Clin Oncol; 2014 Aug; 19(4):579-85. PubMed ID: 24072388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
    Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
    Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy.
    He J; Shen D; Chung DU; Saxton RE; Whitelegge JP; Faull KF; Chang HR
    Int J Oncol; 2009 Oct; 35(4):683-92. PubMed ID: 19724903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer.
    Pietrowska M; Polanska J; Marczak L; Behrendt K; Nowicka E; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2010 Jul; 8():66. PubMed ID: 20618994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.